Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 256.30 billion as of March 9, 2026. Its market cap has increased by 169.97% in one year.

Market Cap

256.30B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

153.47

Stock Price

9,260.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 256.30B, an increase of 790.69%. That is a compound annual growth rate of 7.42%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	256.30B	8.69%
Dec 30, 2025	235.81B	137.66%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BNC Korea	277.68B
JW Holdings	274.69B
CMG Pharmaceutical	266.12B
Boditech Med	263.58B
Korea United Pharm	291.76B
Huons	306.44B
Suheung	240.73B
Ilyang Pharmaceutical Co.,Ltd	233.92B

Market Cap Rankings